Dr Joakim E Swedberg
Title
Cited by
Cited by
Year
Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4
JE Swedberg, LV Nigon, JC Reid, SJ de Veer, CM Walpole, CR Stephens, ...
Chemistry & biology 16 (6), 633-643, 2009
1272009
Cyclotides as a basis for drug design
DJ Craik, JE Swedberg, JS Mylne, M Cemazar
Expert opinion on drug discovery 7 (3), 179-194, 2012
1092012
Disulfide-rich macrocyclic peptides as templates in drug design
SE Northfield, CK Wang, CI Schroeder, T Durek, MW Kan, JE Swedberg, ...
European journal of medicinal chemistry 77, 248-257, 2014
1042014
Mastering the canonical loop of serine protease inhibitors: enhancing potency by optimising the internal hydrogen bond network
JE Swedberg, SJ De Veer, KC Sit, CF Reboul, AM Buckle, JM Harris
PloS one 6 (4), e19302, 2011
722011
Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment
Y Dong, C Stephens, C Walpole, JE Swedberg, GM Boyle, PG Parsons, ...
PloS one 8 (2), e57056, 2013
632013
Exploring experimental and computational markers of cyclic peptides: charting islands of permeability
CK Wang, SE Northfield, JE Swedberg, B Colless, S Chaousis, DA Price, ...
European journal of medicinal chemistry 97, 202-213, 2015
582015
Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitro
CI Schroeder, JE Swedberg, JM Withka, KJ Rosengren, M Akcan, ...
Chemistry & biology 21 (2), 284-294, 2014
562014
Engineered protease inhibitors based on sunflower trypsin inhibitor-1 (SFTI-1) provide insights into the role of sequence and conformation in Laskowski mechanism inhibition
SJ de Veer, JE Swedberg, M Akcan, KJ Rosengren, M Brattsand, DJ Craik, ...
Biochemical Journal 469 (2), 243-253, 2015
542015
The temperature activated HtrA protease from pathogen Chlamydia trachomatis acts as both a chaperone and protease at 37 C
W Huston, Swedberg, J E, J Harris, TP Walsh, S Mathews, P Timms
FEBS Letters 581 (18), 3382-3386, 2007
512007
Selective substrates and inhibitors for kallikrein-related peptidase 7 (KLK7) shed light on KLK proteolytic activity in the stratum corneum
SJ de Veer, L Furio, JE Swedberg, CA Munro, M Brattsand, JA Clements, ...
Journal of Investigative Dermatology 137 (2), 430-439, 2017
502017
Improving the selectivity of engineered protease inhibitors: optimizing the P2 prime residue using a versatile cyclic peptide library
SJ de Veer, CK Wang, JM Harris, DJ Craik, JE Swedberg
Journal of medicinal chemistry 58 (20), 8257-8268, 2015
492015
Conformational flexibility is a determinant of permeability for cyclosporin
CK Wang, JE Swedberg, PJ Harvey, Q Kaas, DJ Craik
The Journal of Physical Chemistry B 122 (8), 2261-2276, 2018
452018
Design of potent and selective cathepsin G inhibitors based on the sunflower trypsin inhibitor-1 scaffold
JE Swedberg, CY Li, SJ De Veer, CK Wang, DJ Craik
Journal of medicinal chemistry 60 (2), 658-667, 2017
412017
Mechanism‐based selection of a potent kallikrein‐related peptidase 7 inhibitor from a versatile library based on the sunflower trypsin inhibitor SFTI‐1
SJ De Veer, SS Ukolova, CA Munro, JE Swedberg, AM Buckle, JM Harris
Peptide Science 100 (5), 510-518, 2013
392013
Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia
JE Swedberg, SJ de Veer, JM Harris
Walter de Gruyter 391 (4), 357-374, 2010
382010
Non-combinatorial library screening reveals subsite cooperativity and identifies new high-efficiency substrates for kallikrein-related peptidase 14
SJ de Veer, JE Swedberg, EA Parker, JM Harris
Biological chemistry 393 (5), 331-341, 2012
362012
Plasmin substrate binding site cooperativity guides the design of potent peptide aldehyde inhibitors
JE Swedberg, JM Harris
Biochemistry 50 (39), 8454-8462, 2011
362011
Effects of cyclization on peptide backbone dynamics
CK Wang, JE Swedberg, SE Northfield, DJ Craik
The journal of physical chemistry B 119 (52), 15821-15830, 2015
302015
Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
SJ De Veer, JE Swedberg, M Brattsand, JA Clements, JM Harris
Biological chemistry 397 (12), 1237-1249, 2016
292016
Direct and indirect mechanisms of KLK4 inhibition revealed by structure and dynamics
BT Riley, O Ilyichova, MGS Costa, BT Porebski, SJ De Veer, JE Swedberg, ...
Scientific reports 6 (1), 1-14, 2016
282016
The system can't perform the operation now. Try again later.
Articles 1–20